Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Head & Neck 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 23Lung Neoplasms 12Prostatic Neoplasms 10Squamous Cell Carcinoma of Head and Neck 8Breast Neoplasms 5Stomach Neoplasms 4Prostatic Neoplasms, Castration-Resistant 4Neoplasms 4Neoplasm Metastasis 3Endometrial Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Oropharyngeal Neoplasms 2Nasopharyngeal Carcinoma 2Melanoma 2Lymphoid Interstitial Pneumonia 2Head and Neck Neoplasms 2HER2-positive Breast Cancer 2Esophageal Neoplasms 2Anatomic Stage I Breast Cancer AJCC v8 2Vaccinia 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urothelial Cancer 1Tongue Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Solid Tumors 1

Interventions

Oxaliplatin 8Fluorouracil 8pembrolizumab 7Paclitaxel 6Trastuzumab 5Leucovorin 5Capecitabine 5Specimen Handling 4Radiation 4Cisplatin 4Carboplatin 4tislelizumab 3patritumab deruxtecan 3Taxes 3Radiotherapy 3Nivolumab 3ulixertinib 2trastuzumab deruxtecan 2trastuzumab biosimilar HLX02 2durvalumab 2Surgical Procedures, Operative 2Ramucirumab 2Pemetrexed 2PF-05280014 2Ontruzant 2Ogivri 2Magnetic Resonance Spectroscopy 2Irinotecan 2Immunotherapy 2Exercise 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Esophageal Neoplasms × Docetaxel × 30 days × Clear all
NCT05094336 2026-05-28

MTAPESTRY 101

Amgen

Phase 1/2 Active not recruiting
329 enrolled
CNSGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Glioma, Stomach Neoplasms

NCT06123338 2026-05-28

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
49 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡